241 related articles for article (PubMed ID: 18220700)
1. The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.
Curtiss LK; Tobias PS
Curr Drug Targets; 2007 Dec; 8(12):1230-8. PubMed ID: 18220700
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors in atherosclerosis.
Tobias PS; Curtiss LK
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1453-5. PubMed ID: 18031244
[TBL] [Abstract][Full Text] [Related]
3. Global TLR2 and 4 deficiency in mice impacts bone resorption, inflammatory markers and atherosclerosis to polymicrobial infection.
Chukkapalli SS; Velsko IM; Rivera-Kweh MF; Larjava H; Lucas AR; Kesavalu L
Mol Oral Microbiol; 2017 Jun; 32(3):211-225. PubMed ID: 27224005
[TBL] [Abstract][Full Text] [Related]
4. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
Hajishengallis G; Sharma A; Russell MW; Genco RJ
Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.
Kapelouzou A; Giaglis S; Peroulis M; Katsimpoulas M; Moustardas P; Aravanis CV; Kostakis A; Karayannakos PE; Cokkinos DV
J Vasc Res; 2017; 54(3):156-169. PubMed ID: 28478461
[TBL] [Abstract][Full Text] [Related]
6. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.
Hayashi C; Madrigal AG; Liu X; Ukai T; Goswami S; Gudino CV; Gibson FC; Genco CA
J Innate Immun; 2010; 2(4):334-43. PubMed ID: 20505314
[TBL] [Abstract][Full Text] [Related]
7. Multiple roles of Toll-like receptor signaling in atherosclerosis.
Björkbacka H
Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
[TBL] [Abstract][Full Text] [Related]
8. Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4.
Shinohara M; Hirata K; Yamashita T; Takaya T; Sasaki N; Shiraki R; Ueyama T; Emoto N; Inoue N; Yokoyama M; Kawashima S
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2384-91. PubMed ID: 17872459
[TBL] [Abstract][Full Text] [Related]
9. Modulation of atherosclerosis in mice by Toll-like receptor 2.
Mullick AE; Tobias PS; Curtiss LK
J Clin Invest; 2005 Nov; 115(11):3149-56. PubMed ID: 16211093
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of Toll-like receptors in atherosclerosis.
Curtiss LK; Tobias PS
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S340-5. PubMed ID: 18980945
[TBL] [Abstract][Full Text] [Related]
11. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis.
Gibson FC; Ukai T; Genco CA
Front Biosci; 2008 Jan; 13():2041-59. PubMed ID: 17981690
[TBL] [Abstract][Full Text] [Related]
12. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.
Mullick AE; Soldau K; Kiosses WB; Bell TA; Tobias PS; Curtiss LK
J Exp Med; 2008 Feb; 205(2):373-83. PubMed ID: 18250194
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte toll-like receptor expression in end-stage kidney disease.
Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
[TBL] [Abstract][Full Text] [Related]
14. Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages.
Megías J; Yáñez A; Moriano S; O'Connor JE; Gozalbo D; Gil ML
Stem Cells; 2012 Jul; 30(7):1486-95. PubMed ID: 22511319
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells.
Shuang Chen ; Wong MH; Schulte DJ; Arditi M; Michelsen KS
J Endotoxin Res; 2007; 13(5):281-96. PubMed ID: 17986487
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors and atherosclerosis: key contributors in disease and health?
Mullick AE; Tobias PS; Curtiss LK
Immunol Res; 2006; 34(3):193-209. PubMed ID: 16891671
[TBL] [Abstract][Full Text] [Related]
17. Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages.
Li H; Hong F; Pan S; Lei L; Yan F
Inflammation; 2016 Feb; 39(1):199-208. PubMed ID: 26277357
[TBL] [Abstract][Full Text] [Related]
18. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
[TBL] [Abstract][Full Text] [Related]
19. Functional role for toll-like receptors in atherosclerosis and arterial remodeling.
Vink A; de Kleijn DP; Pasterkamp G
Curr Opin Lipidol; 2004 Oct; 15(5):515-21. PubMed ID: 15361786
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation.
Kawakami A; Osaka M; Aikawa M; Uematsu S; Akira S; Libby P; Shimokado K; Sacks FM; Yoshida M
Circ Res; 2008 Dec; 103(12):1402-9. PubMed ID: 18974386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
